Bayer boosts its gene therapy portfolio with lipid nanoparticle technology from Acuitas Therapeutics Inc.
Up To Date
Latest News
Bergen-based Cytovation ASA has raised US$8m in a Series A extension round to push its cancer compound CyPep-1...
The Chemspec Europe 2023 provided insights into current challenges of the chemical industry, as well as the...
Italian researchers have successfully ameliorated several IL-1-based autoimmune disorders by gene therapy into...
Bristol-based eXmoor Pharma Ltd has completed a US$35m Series A financing to expand its cell and gene therapy...
Leiden-based VarmX BV said it will use the €30m Series B2 money to complete the data required for IND approval...
Share
